Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions
Condition(s):Prostate CancerLast Updated:March 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:March 28, 2023Completed
Condition(s):Neuroendocrine TumorsLast Updated:March 5, 2020Completed
Condition(s):Prostate Cancer; Positron Emission Tomography; PSMALast Updated:October 27, 2022Recruiting
Condition(s):Head and Neck NeoplasmsLast Updated:January 29, 2020Withdrawn
Condition(s):Neuroendocrine Tumor Carcinoid; Neuroendocrine Tumor of Pancreas; Gep NetLast Updated:September 22, 2023Active, not recruiting
Condition(s):Dilated Cardiomyopathies, Idiopathic; Heart Failure, Systolic; Ventricular Remodeling; Electrical RemodelingLast Updated:December 20, 2023Completed
Condition(s):CYP3A4 InductionLast Updated:July 11, 2011Completed
Condition(s):Spontaneous Coronary Artery DissectionLast Updated:April 20, 2021Not yet recruiting
Condition(s):Myocardial InfarctionLast Updated:December 6, 2023Completed
Condition(s):Perimenopause-Related DepressionLast Updated:February 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.